Sort   by:  
 Page size 
UnknownCould HE4 level measurements during first-line chemotherapy predict response to treatment among ovarian cancer patients?
Not available
S-EPMC5870956 | biostudies-literature
UnknownCancer risks in first degree relatives of BRCA1 mutation carriers: effects of mutation and proband disease status.
Not available
S-EPMC2564518 | biostudies-literature
UnknownIntegrin beta3 Leu33Pro polymorphism increases BRCA1-associated ovarian cancer risk.
Not available
S-EPMC2740893 | biostudies-literature
UnknownOvarian cancer risk in Polish BRCA1 mutation carriers is not associated with the prohibitin 3' untranslated region polymorphism.
Not available
S-EPMC2364631 | biostudies-literature
UnknownAssociation of common WRAP 53 variant with ovarian cancer risk in the Polish population.
Not available
S-EPMC3563948 | biostudies-literature
UnknownA personalised approach to prostate cancer screening based on genotyping of risk founder alleles.
Not available
S-EPMC3694242 | biostudies-literature
UnknownInvestigation of Exomic Variants Associated with Overall Survival in Ovarian Cancer.
Not available
S-EPMC4779669 | biostudies-literature
UnknownVariation in NF-κB signaling pathways and survival in invasive epithelial ovarian cancer.
Not available
S-EPMC4082406 | biostudies-literature
UnknownIncreased FOXJ1 protein expression is associated with improved overall survival in high-grade serous ovarian carcinoma: an Ovarian Tumor Tissue Analysis Consortium Study.
Not available
S-EPMC9814937 | biostudies-literature
UnknownDose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer.
Not available
S-EPMC5744673 | biostudies-literature
Sort   by:  
 Page size